echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > After the expiration of the national procurement, the price of cephalexin renewed bid soared by nearly 90%?

    After the expiration of the national procurement, the price of cephalexin renewed bid soared by nearly 90%?

    • Last Update: 2021-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The price of cephalexin continues to rise after the national harvest

    01

    01

    The price of cephalexin renewed bid soared by nearly 90%?

    The price of cephalexin renewed bid soared by nearly 90%?

    A few days ago, Shanxi Province Pharmaceutical Equipment Centralized Bidding and Purchasing Center issued a notice stating that Shanxi had participated in the centralized procurement of cephalexin oral normal-release dosage forms organized by Hebei Province


    Source: Shanxi Province Pharmaceutical Equipment Centralized Bidding and Purchasing Center

    Cephalexin oral normal-release dosage form is the product selected by the exclusive enterprise in the second batch of national centralized drug procurement.


    It is worth noting that in the second batch of national drug procurement list, cephalexin capsules 0.


    Cyberlan noted that Shaanxi, Liaoning, Inner Mongolia Autonomous Region, Jilin Province, Heilongjiang Province, Sichuan Province, Tibet Autonomous Region, Hubei Province, Zhejiang, Guangdong and other provinces have all issued cephalexin renewal documents


    According to statistics from Yaorongyun, in the results of the announced renewal of the bid, the price of cephalexin oral regular-release dosage form has risen sharply compared with the second batch of national sources


    Among them, the result of the centralized procurement of cephalexin led by the 10 provincial alliances of Guangdong Province was: capsules and sustained-release tablets each won the bid, and the granule group "due to the lowest" and "comparable unit price" higher than the "comparable unit price" lowest oral routine.


    The prices of expired drugs in centralized procurement continue to be reduced during the contract renewal process, which has been defaulted by the industry as a routine operation


    Why has the price of cephalexin renewed soared by nearly 90%?

    02

    02

    Why did the price of centralized procurement renewal increase instead of falling?

    Why did the price of centralized procurement renewal increase instead of falling?

    It may be possible to find out in the documents issued by Hebei Province


    Purchasing documents stipulate that the declared price shall not be higher than the lowest effective online price of the same type and specification of the company in all provinces (cities, districts) and the trading platform of Hebei Province Pharmaceutical Centralized Purchasing Network from January 1, 2020 to January 1, 2021 Effective minimum storage price


    In the second batch of national centralized procurement, five pharmaceutical companies, Hebei Huamin Pharmaceutical, Kelun Pharmaceutical, CSPC Ouyi Pharmaceutical, Luoxin Pharmaceutical, and Yangzijiang Pharmaceutical Group, competed for the oral dosage form of cephalexin.


    With the rapid development of generic drugs today, Cyberlan searched the list of chemical drugs that were newly approved by the National Food and Drug Administration and passed the consistency evaluation of the quality and efficacy of generic drugs, and found that there were 21 batch numbers of cephalexin capsules


    Source: State Drug Administration

    There are many factors for the price increase of medicines, but it has become the consensus of the industry to respect the reasonable profits of pharmaceutical companies


    In order to avoid the emergence of "winning bids" for selected products, the National Medical Insurance Administration pays more attention to the supply of selected products


    Although the policy is milder for generic drug companies, it is the general trend to move from imitation to innovation


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.